March 2025 Life Sciences Update

Houston

MARKETS CONTENTS

Market Summary

Public & Private Funding (2024)

Fast Lab Stats

• With a high concentration of employment, entrepreneurial drive and an active investment community, the Houston region is fertile ground for innovation in biotech and life sciences. • Houston is home to the world’s largest medical complex, the Texas Medical Center, which plays a pivotal role in positioning the region at the forefront of the biotech and life sciences sectors. More than 60 institutions operate within the 50-msf Texas Medical Center, serving as a catalyst for Houston’s collaborative ecosystem and setting the stage for groundbreaking research by providing direct access to nearly 5,000 active clinical trials. • Recent real estate investments further supporting Houston’s life sciences research and development include TMC’s Helix Park and industry research hub Dynamic One. In the Medical District, Hines’ Levit Green is now leasing over 200,000 sf of lab and office space as part of its future 53-acre district. On the northeast side of the Houston market, McCord Development recently broke ground on its master-planned Generation Park, a new Center for Biotechnology. In The Woodlands, Alexandria Real Estate plans to develop 8800 Technology Forest Place into 325,000 sf of Class A space, part of which is already under construction.

Company

Deal Type

Completed

VC Round

$ Raised (MM)

5.1 MSF Total Inventory 680,000 SF Under Construction 1.1 MSF Proposed 27.5K Total Life Sciences Employment 76.5% Life Sciences Employment 10-Year Growth Rate

Procyrion

Later Stage VC

Feb 2024

6th Round

$57.7

ImmunoGenesis

Later Stage VC

Apr 2024

1st Round

$44.4

March Biosciences

Early Stage VC

Oct 2024

2nd Round

$28.4

Tvardi Therapeutics (NAS: TVRD)

Later Stage VC

Dec 2024

3rd Round

$28.0

VenoStent

Later Stage VC

Jun 2024

3rd Round

$20.0

CoRegen

Later Stage VC

Feb 2024

2nd Round

$14.5

CrossBridge Bio

Early Stage VC

Nov 2024

2nd Round

$10.8

Pulmotect

Later Stage VC

Sep 2024

4th Round

$10.3

OncoMAGNETx

Early Stage VC

Apr 2024

1st Round

$10.1

PranaX

Early Stage VC

Jan 2024

2nd Round

$10.0

Representative Lease Transactions (2024)

Representative Life Sciences Companies

Life Sciences Labor: Average Monthly Job Postings

Company

Address

Size (SF)

New/Renewal

Type

Quarter Landlord

Company

Type

1,600

Lonza Biologics

Regional Office

1,400

Biologi cs CDMO Life Science Life Science

Warmack Investments

Bionova Scientific

2625 Research Forest

100,000 New

Q2

Alcon Manufacturing

Regional Office

1,200

The US Oncology

HQ

1,000

BlueBonnet Nutrition

HQ

PranaX

Levit Green/3131 Holcombe Blvd.

7,500 New

Q1

Hines

800

Merit Medical Systems

HQ

600

Texas Medical Center

Artidis

TMC3 Collaborative Building

2,000 New

Q3

Millar Instruments

HQ

400

Cellipont Bioservices

HQ

200

Biotics Research Corporation

HQ

-

The National Space Biomedical Research Institute

2020 2021

2022

2023

2024

HQ

Hires Unique Postings

Marker Therapeutics

HQ

March Biosciences

HQ

Top NIH-Funded Institutions (2020-2024)

Bio Degree-Awarding Institutions, Metro Area

Annual Life Sciences Degree Completions 2013 3,096

$1.7B Baylor College of Medicine $910M University of Texas MD Anderson Cancer Center $709M University of Texas Health Science Center Houston

University of Texas MD Anderson School of Health Professionals

•

Rice University

• • • •

2023 4,610 Up 49%

University of Houston

Texas Southern University

Houston Christian University

University of St. Thomas

•

Sherra Gilbert sherra.gilbert@cushwake.com Research Contributors

Sources: Cushman & Wakefield Research, CoStar, National Institutes of Health (NIH), Lightcast, Pitchbook

Cushman & Wakefield

76